Research Progress on Lymphoproliferative Diseases after Lung Transplantation

Abstract

With the development of surgical methods and pharmaceutical preparations, more patients with benign end-stage lung disease can receive treatment of lung transplants. Not only the number of surgeries has increased to 4,000 per year, but also the survival time has been growing longer. Ten years ago, a lot of medical experts thought that post-transplant lymphoproliferative disease was a rare disease, but this disease has received more and more attention because of increasing of surgeries. PTLD is a serious and rare post-transplant complication. Compared with other organ transplants, the incidence of heart, lung, and heart lung transplantation is extremely high. The 5-year survival rate is 29%, and the median survival period is 10month. Risk factors for morbidity are related to the use of immunosuppressive agents, viral infections, type of transplanted organ, gender, age et al. This article will describe the incidence, risk factors, pathogenic mechanism, treatment methods and latest research progress of lymphoproliferative diseases after lung transplantation recently by providing new ideas on hotspots.

Authors and Affiliations

Yue Ma, Jun Chen

Keywords

Related Articles

A Case of Treatment Resistant Depression who did not Respond Sufficiently to ECT (Electroconvulsive Therapy) and Responded to rTMS (Repetitive Transcranial Magnetic Stimulation)

The use of repetitive transcranial magnetic stimulation has grown over the last ten years since the FDA approval in 2008 and has been also included in NICE UK as an optional treatment [1] and it is likely to continue to...

Knowledge, Attitude and Acceptance of Modern Family Planning Method Among Women Attending Post–Natal Clinic in Ayeka Basic Health Centre in Okitipupa Local Government Area, Ondo State, Nigeria

Unintended or unplanned pregnancy poses a major economical, psychological, social, and/or religious challenge in women of reproductive age, especially in developing countries. Available data indicates that Niger...

Aligning Pathology Assessment in a Learner-Cantered Undergraduate Medical Curriculum

Introduction: The Bond Medical Program delivers pathology in the preclinical years through interactive learning. Assessment for learning demandsfit-for-purpose assessmentthat aligns with the curriculum. In Year 2 of the...

Brain Imaging: a Promising Biomarker for Pain

Clinicians and researchers have the problem of objectively assessing the intensity and characteristics of pain. Furthermore, the widespread use of Visual-Analogue scales during the past decade highlights the need for a r...

What Should Oral Health Clinicians Tell Their Patients About Oral HPV? A Brief Review

In the United States, it is estimated that there are at least 20 million new cases of sexually transmitted infections (STIs) each year, with a prevalence of 110 million people infected, and costing the country 16 billion...

Download PDF file
  • EP ID EP588429
  • DOI 10.26717/BJSTR.2018.08.001651
  • Views 156
  • Downloads 0

How To Cite

Yue Ma, Jun Chen (2018). Research Progress on Lymphoproliferative Diseases after Lung Transplantation. Biomedical Journal of Scientific & Technical Research (BJSTR), 8(3), 6496-6499. https://europub.co.uk/articles/-A-588429